Approval · Notice of Compliance 31760 · 2023
IMURAN: Notice of Compliance 31760
Issued September 28, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31760
- Date
- September 28, 2023
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph (PM) with the risk of cholestasis of pregnancy and pellagra; removal of section 14.3 Comparative Bioavailability Studies from the PM.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMURAN | Not yet assigned | — |
Medicinal ingredients
- AZATHIOPRINE SODIUM 50 MG per VIAL
- AZATHIOPRINE 50 MG per TAB